193 related articles for article (PubMed ID: 15319452)
21. Distinctive roles for prolactin and growth hormone in the activation of signal transducer and activator of transcription 5 in pancreatic islets of langerhans.
Brelje TC; Stout LE; Bhagroo NV; Sorenson RL
Endocrinology; 2004 Sep; 145(9):4162-75. PubMed ID: 15142985
[TBL] [Abstract][Full Text] [Related]
22. Expression of functional prolactin receptors in nonpregnant human endometrium: janus kinase-2, signal transducer and activator of transcription-1 (STAT1), and STAT5 proteins are phosphorylated after stimulation with prolactin.
Jabbour HN; Critchley HO; Boddy SC
J Clin Endocrinol Metab; 1998 Jul; 83(7):2545-53. PubMed ID: 9661641
[TBL] [Abstract][Full Text] [Related]
23. Complex regulation of the fibroblast growth factor-binding protein in MDA- MB-468 breast cancer cells by CCAAT/enhancer-binding protein beta.
Kagan BL; Henke RT; Cabal-Manzano R; Stoica GE; Nguyen Q; Wellstein A; Riegel AT
Cancer Res; 2003 Apr; 63(7):1696-705. PubMed ID: 12670924
[TBL] [Abstract][Full Text] [Related]
24. PAK1 regulates breast cancer cell invasion through secretion of matrix metalloproteinases in response to prolactin and three-dimensional collagen IV.
Rider L; Oladimeji P; Diakonova M
Mol Endocrinol; 2013 Jul; 27(7):1048-64. PubMed ID: 23744893
[TBL] [Abstract][Full Text] [Related]
25. SRC family kinases accelerate prolactin receptor internalization, modulating trafficking and signaling in breast cancer cells.
Piazza TM; Lu JC; Carver KC; Schuler LA
Mol Endocrinol; 2009 Feb; 23(2):202-12. PubMed ID: 19056863
[TBL] [Abstract][Full Text] [Related]
26. Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.
Arendt LM; Rugowski DE; Grafwallner-Huseth TA; Garcia-Barchino MJ; Rui H; Schuler LA
Breast Cancer Res; 2011 Jan; 13(1):R11. PubMed ID: 21276249
[TBL] [Abstract][Full Text] [Related]
27. Complex functions of AP-1 transcription factors in differentiation and survival of PC12 cells.
Leppä S; Eriksson M; Saffrich R; Ansorge W; Bohmann D
Mol Cell Biol; 2001 Jul; 21(13):4369-78. PubMed ID: 11390664
[TBL] [Abstract][Full Text] [Related]
28. Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells.
Eriksson M; Taskinen M; Leppä S
J Cell Physiol; 2007 Feb; 210(2):538-48. PubMed ID: 17111371
[TBL] [Abstract][Full Text] [Related]
29. Prolactin regulation of neonatal ovine uterine gland morphogenesis.
Carpenter KD; Gray CA; Noel S; Gertler A; Bazer FW; Spencer TE
Endocrinology; 2003 Jan; 144(1):110-20. PubMed ID: 12488336
[TBL] [Abstract][Full Text] [Related]
30. Estrogens do not modify MAP kinase-dependent nuclear signaling during stimulation of early G(1) progression in human breast cancer cells.
Caristi S; Galera JL; Matarese F; Imai M; Caporali S; Cancemi M; Altucci L; Cicatiello L; Teti D; Bresciani F; Weisz A
Cancer Res; 2001 Sep; 61(17):6360-6. PubMed ID: 11522626
[TBL] [Abstract][Full Text] [Related]
31. Differentiation-dependent prolactin responsiveness and stat (signal transducers and activators of transcription) signaling in rat ovarian cells.
Russell DL; Richards JS
Mol Endocrinol; 1999 Dec; 13(12):2049-64. PubMed ID: 10598581
[TBL] [Abstract][Full Text] [Related]
32. Tyrosine phosphorylation of Grb2: role in prolactin/epidermal growth factor cross talk in mammary epithelial cell growth and differentiation.
Haines E; Minoo P; Feng Z; Resalatpanah N; Nie XM; Campiglio M; Alvarez L; Cocolakis E; Ridha M; Di Fulvio M; Gomez-Cambronero J; Lebrun JJ; Ali S
Mol Cell Biol; 2009 May; 29(10):2505-20. PubMed ID: 19273609
[TBL] [Abstract][Full Text] [Related]
33. PRL modulates cell cycle regulators in mammary tumor epithelial cells.
Schroeder MD; Symowicz J; Schuler LA
Mol Endocrinol; 2002 Jan; 16(1):45-57. PubMed ID: 11773438
[TBL] [Abstract][Full Text] [Related]
34. Activation and inhibition of the AP-1 complex in human breast cancer cells.
Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
[TBL] [Abstract][Full Text] [Related]
35. Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells.
Scotti ML; Langenheim JF; Tomblyn S; Springs AE; Chen WY
Breast Cancer Res Treat; 2008 Sep; 111(2):241-50. PubMed ID: 17955362
[TBL] [Abstract][Full Text] [Related]
36. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
37. A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.
Hachim IY; Shams A; Lebrun JJ; Ali S
Hum Pathol; 2016 Jul; 53():142-52. PubMed ID: 26980025
[TBL] [Abstract][Full Text] [Related]
38. Prolactin activates Ras via signaling proteins SHC, growth factor receptor bound 2, and son of sevenless.
Erwin RA; Kirken RA; Malabarba MG; Farrar WL; Rui H
Endocrinology; 1995 Aug; 136(8):3512-8. PubMed ID: 7628388
[TBL] [Abstract][Full Text] [Related]
39. 16-kDa prolactin down-regulates inducible nitric oxide synthase expression through inhibition of the signal transducer and activator of transcription 1/IFN regulatory factor-1 pathway.
Lee SH; Nishino M; Mazumdar T; Garcia GE; Galfione M; Lee FL; Lee CL; Liang A; Kim J; Feng L; Eissa NT; Lin SH; Yu-Lee LY
Cancer Res; 2005 Sep; 65(17):7984-92. PubMed ID: 16140971
[TBL] [Abstract][Full Text] [Related]
40. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
